eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | leukoplakia |
| Symptom | C1608408|malignant transformation |
| Sentences | 7 |
| PubMedID- 21225307 | malignant transformation rates of oral leukoplakia range from 0.13 to 17.5%. |
| PubMedID- 26064958 | In particular, we identified some key genes that play crucial roles in the malignant transformation of oral leukoplakia to oral cancer, including 4 hub genes (stat5b, egfr, pdgfrb, stat5a), 5 intra-maoc genes (raf1, pdgfrb, src, prkaca, egfr), 5 inter-maoc genes (prkca, mapk1, mapk3, esr1, fyn) and 8 mirnas (hsa-mir-499-5p, hsa-mir-549, hsa-mir-205, hsa-mir-525-5p, hsa-mir-21, hsa-mir-323-3p, hsa-mir-423-3p, hsa-mir-491-3p). |
| PubMedID- 24403051 | Egfr inhibitors may thus be potentially useful in preventing malignant transformation of such leukoplakia lesions (51). |
| PubMedID- 24345883 | Moreover, ezh2 has been found to promote malignant transformation of oral leukoplakia, epithelial to mesenchymal transition and cancer stem cell maintenance in head neck cancers . |
| PubMedID- 22471854 | Conclusion: although podoplanin expression and the sin-classification served as factors to predict malignant transformation in patients with oral leukoplakia in univariate analysis, no significant impact was found for both factors in multivariate analysis. |
| PubMedID- 21743397 | malignant transformation of oral leukoplakia occurs on average in 1% of cases per year (2). |
| PubMedID- 22623931 | 1 the malignant transformation rates of oral leukoplakia have been reported from 1 to 17% with highest transformation rate for the lesions on floor of the mouth, soft palate and tongue. |
Page: 1